You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

INDOCYANINE GREEN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for indocyanine green and what is the scope of patent protection?

Indocyanine green is the generic ingredient in three branded drugs marketed by Renew Pharms and Novadaq Tech, and is included in three NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Indocyanine green has fifty-five patent family members in eleven countries.

There are three drug master file entries for indocyanine green. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for INDOCYANINE GREEN
Recent Clinical Trials for INDOCYANINE GREEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Alabama at BirminghamPhase 4
Stryker NordicPhase 4
Northwestern UniversityPhase 4

See all INDOCYANINE GREEN clinical trials

Generic filers with tentative approvals for INDOCYANINE GREEN
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE;INJECTION
⤷  Sign Up⤷  Sign Up10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE;INJECTION
⤷  Sign Up⤷  Sign Up50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE;INJECTION

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Medical Subject Heading (MeSH) Categories for INDOCYANINE GREEN
Anatomical Therapeutic Chemical (ATC) Classes for INDOCYANINE GREEN
Paragraph IV (Patent) Challenges for INDOCYANINE GREEN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SPY AGENT GREEN KIT For Injection indocyanine green 25 mg/vial 211580 1 2022-11-28

US Patents and Regulatory Information for INDOCYANINE GREEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Renew Pharms IC-GREEN indocyanine green INJECTABLE;INJECTION 011525-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for INDOCYANINE GREEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 ⤷  Sign Up ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 ⤷  Sign Up ⤷  Sign Up
Novadaq Tech SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580-001 Nov 21, 2018 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for INDOCYANINE GREEN

Country Patent Number Title Estimated Expiration
South Korea 102012880 ⤷  Sign Up
South Korea 20190022940 형광-조정 광전용적맥파 측정기를 사용한 조직 내의 절대적인 혈류의 정량화 (- QUANTIFICATION OF ABSOLUTE BLOOD FLOW IN TISSUE USING FLUORESCENCE-MEDIATED PHOTOPLETHYSMOGRAPHY) ⤷  Sign Up
European Patent Office 2268201 EVALUATION DE PERFUSION DE VAISSEAUX PERFORANTS (EVALUATION OF PERFUSION OF PERFORATOR VESSELS) ⤷  Sign Up
European Patent Office 2618737 LOCALISATION ET ANALYSE DE LAMBEAUX PERFORANTS POUR UNE CHIRURGIE PLASTIQUE ET RECONSTRUCTIVE (LOCATING AND ANALYZING PERFORATOR FLAPS FOR PLASTIC AND RECONSTRUCTIVE SURGERY) ⤷  Sign Up
European Patent Office 3733055 PROCÉDÉ D'ÉVALUATION D'UNE OPACIFICATION D'UN TISSU MYOCARDIQUE (METHOD FOR EVALUATING BLUSH IN MYOCARDIAL TISSUE) ⤷  Sign Up
South Korea 101621107 ⤷  Sign Up
Russian Federation 2011111078 ОПРЕДЕЛЕНИЕ МЕСТОПОЛОЖЕНИЯ И АНАЛИЗ ЛОСКУТОВ ПЕРФОРАТОРА ДЛЯ ПЛАСТИЧЕСКОЙ И ВОССТАНОВИТЕЛЬНОЙ ХИРУРГИИ ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.